Evidence map›Paper›PMID 36395362›Full record

ArticleOncotarget2022

Treasures from trash in cancer research.

Fabiano Cordeiro Moreira, Dionison Pereira Sarquis, Jorge Estefano Santana de Souza, Daniel de Souza Avelar, Taíssa Maria Thomaz Araújo, André Salim Khayat, Sidney Emanuel Batista Dos Santos, Paulo Pimentel de Assumpção

Abstract read
In one paragraph

Article in Oncotarget, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Fabiano Cordeiro Moreira *Núcleo de Pesquisas em Oncologia/Universidade Federal do Pará, Belém, Pará, Brazil.
Dionison Pereira Sarquis *Núcleo de Pesquisas em Oncologia/Universidade Federal do Pará, Belém, Pará, Brazil.
Jorge Estefano Santana de SouzaInstituto Metrópole Digital/Universidade Federal do Rio Grande do Norte, Natal, Brazil.
Daniel de Souza AvelarNúcleo de Pesquisas em Oncologia/Universidade Federal do Pará, Belém, Pará, Brazil.
Taíssa Maria Thomaz AraújoNúcleo de Pesquisas em Oncologia/Universidade Federal do Pará, Belém, Pará, Brazil.
André Salim KhayatNúcleo de Pesquisas em Oncologia/Universidade Federal do Pará, Belém, Pará, Brazil.
Sidney Emanuel Batista Dos SantosNúcleo de Pesquisas em Oncologia/Universidade Federal do Pará, Belém, Pará, Brazil.
Paulo Pimentel de AssumpçãoNúcleo de Pesquisas em Oncologia/Universidade Federal do Pará, Belém, Pará, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCancer research has significantly improved in recent years, primarily due to next-generation sequencing (NGS) technology. Consequently, an enormous amount of genomic and transcriptomic data has been generated. In most cases, the data needed for research goals are used, and unwanted reads are discarded. However, these eliminated data contain relevant information. Aiming to test this hypothesis, genomic and transcriptomic data were acquired from public datasets. MATERIALS AND

methodsMetagenomic tools were used to explore genomic cancer data; additional annotations were used to explore differentially expressed ncRNAs from miRNA experiments, and variants in adjacent to tumor samples from RNA-seq experiments were also investigated.

resultsIn all analyses, new data were obtained: from DNA-seq data, microbiome taxonomies were characterized with a similar performance of dedicated metagenomic research; from miRNA-seq data, additional differentially expressed sncRNAs were found; and in tumor and adjacent to tumor tissue data, somatic variants were found.

conclusionsThese findings indicate that unexplored data from NGS experiments could help elucidate carcinogenesis and discover putative biomarkers with clinical applications. Further investigations should be considered for experimental design, providing opportunities to optimize data, saving time and resources while granting access to multiple genomic perspectives from the same sample and experimental run.

Indexed as

MicroRNAsNeoplasmsRNA, Small UntranslatedGenomicsHigh-Throughput Nucleotide SequencingHumansSoftwareMicroRNAsRNA, Small Untranslatedcancer metagenomicscancer sncRNA expressionRNA-Seq variant calling

Identifiers

PMID36395362
PMCPMC9671455

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.